| RS2136213505 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2136213668 |
MMAB
|
Health Risk |
Pathogenic |
Methylmalonic aciduria, cblB type |
| RS2136213885 |
CHD4
|
Health Risk |
Likely pathogenic |
— |
| RS2136215102 |
CHD4
|
Health Risk |
Likely pathogenic |
Sifrim-Hitz-Weiss syndrome, Sifrim-Hitz-Weiss syndrome |
| RS2136216750 |
MVK
|
Health Risk |
Likely pathogenic |
Hyperimmunoglobulin D with periodic fever, Hyperimmunoglobulin D with periodic fever |
| RS2136218596 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2136218711 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS2136219026 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2136219240 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136219729 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136220112 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136220181 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2136220894 |
CHD4
|
Health Risk |
Likely pathogenic |
— |
| RS2136220927 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136221257 |
CHD4
|
Health Risk |
Likely pathogenic |
Ovarian serous cystadenocarcinoma, Ovarian serous cystadenocarcinoma |
| RS2136221943 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136222670 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2136222746 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2136226194 |
PEX5
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2A (Zellweger) |
| RS2136231809 |
RXYLT1
|
Health Risk |
Pathogenic |
— |
| RS2136236619 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136236649 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136236945 |
MVK
|
Health Risk |
Pathogenic |
Hyperimmunoglobulin D with periodic fever, Porokeratosis 3 |
| RS2136237257 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136237909 |
GNS
|
Health Risk |
Pathogenic/Likely pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136238332 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial colorectal cancer type X |
| RS2136238537 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2136238826 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136239127 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2136240508 |
GNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136240561 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2136240892 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Ataxia-telangiectasia syndrome |
| RS2136241341 |
ATM
|
Health Risk |
Pathogenic |
Breast carcinoma, Breast carcinoma |
| RS2136243209 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2136243287 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136243664 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136245530 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136246147 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136247574 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136247644 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136247658 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136247666 |
GNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136248422 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136248430 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136248791 |
VCL
|
Health Risk |
Pathogenic |
— |
| RS2136248862 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136249835 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136249878 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136253236 |
GNS
|
Health Risk |
Likely pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136254229 |
PEX5
|
Health Risk |
Likely pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2136254746 |
PEX5
|
Health Risk |
Pathogenic |
Peroxisome biogenesis disorder 2B, Peroxisome biogenesis disorder 2B |
| RS2136256358 |
HPS1
|
Health Risk |
Pathogenic |
— |
| RS2136259310 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136259376 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136259586 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136259630 |
GNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-III-D |
| RS2136273769 |
EHMT1
|
Health Risk |
Pathogenic |
— |
| RS2136274853 |
EHMT1
|
Health Risk |
Pathogenic |
Kleefstra syndrome 1, Kleefstra syndrome 1 |
| RS2136280484 |
SLC11A2
|
Health Risk |
Pathogenic |
Microcytic anemia with liver iron overload, Microcytic anemia with liver iron overload |
| RS2136287756 |
PHF21A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2136295939 |
OAS1
|
Health Risk |
Pathogenic |
Pulmonary alveolar proteinosis with hypogammaglobulinemia, Pulmonary alveolar proteinosis with hypogammaglobulinemia |
| RS2136306738 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2136307553 |
ATM
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2136308396 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136308670 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2136309423 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Familial cancer of breast, Ataxia-telangiectasia syndrome |
| RS2136311638 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2136312473 |
LEMD3
|
Health Risk |
Pathogenic |
— |
| RS2136312865 |
LEMD3
|
Health Risk |
Pathogenic |
— |
| RS2136313078 |
LEMD3
|
Health Risk |
Pathogenic |
— |
| RS2136313188 |
LEMD3
|
Health Risk |
Pathogenic |
Dermatofibrosis lenticularis disseminata, Dermatofibrosis lenticularis disseminata |
| RS2136313227 |
LEMD3
|
Health Risk |
Pathogenic |
— |
| RS2136313349 |
LEMD3
|
Health Risk |
Pathogenic |
Dermatofibrosis lenticularis disseminata, Dermatofibrosis lenticularis disseminata |
| RS2136313585 |
LEMD3
|
Health Risk |
Pathogenic |
LEMD3-related disorder, LEMD3-related disorder |
| RS2136313589 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136313631 |
LEMD3
|
Health Risk |
Pathogenic |
— |
| RS2136314501 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136314573 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136314701 |
ATM
|
Health Risk |
Pathogenic |
— |
| RS2136315218 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2136317336 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136318333 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2136318895 |
ATM
|
Health Risk |
Likely pathogenic |
ATM-related disorder, ATM-related disorder |
| RS2136319435 |
ATM
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial cancer of breast |
| RS2136319469 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2136320656 |
PLCE1
|
Health Risk |
Likely pathogenic |
Nephrotic syndrome, Nephrotic syndrome |
| RS2136321241 |
OAS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2136327710 |
HPS1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome 1, Hermansky-Pudlak syndrome 1 |
| RS2136330823 |
ATM
|
Health Risk |
Likely pathogenic |
Ataxia-telangiectasia syndrome, Ataxia-telangiectasia syndrome |
| RS2136332132 |
ATM
|
Health Risk |
Pathogenic |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS2136332542 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2136332584 |
ATM
|
Health Risk |
Likely pathogenic |
Breast carcinoma, Breast carcinoma |
| RS2136333690 |
HPS6
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome, Hermansky-Pudlak syndrome |
| RS2136333791 |
HPS6
|
Health Risk |
Pathogenic |
Hermansky-Pudlak syndrome 6, Hermansky-Pudlak syndrome 6 |
| RS2136333814 |
HPS6
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome, Hermansky-Pudlak syndrome |
| RS2136334244 |
HPS6
|
Health Risk |
Pathogenic/Likely pathogenic |
Hermansky-Pudlak syndrome, Hermansky-Pudlak syndrome |
| RS2136334341 |
HPS6
|
Health Risk |
Likely pathogenic |
Hermansky-Pudlak syndrome 6, Hermansky-Pudlak syndrome 6 |
| RS2136334561 |
ATM
|
Health Risk |
Pathogenic/Likely pathogenic |
Ataxia-telangiectasia syndrome, Familial cancer of breast |
| RS2136334661 |
ATM
|
Health Risk |
Pathogenic |
Familial cancer of breast, Familial cancer of breast |
| RS2136335869 |
LEMD3
|
Health Risk |
Pathogenic |
— |